Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

400
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
400
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

535
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
535
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

370
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
370
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

288
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
288
Disorders of Hemostasis01:24

Disorders of Hemostasis

2.4K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.4K
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

9.5K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
9.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Arterial and venous thromboembolism in hospitalized patients with COVID-19: a national multicenter cohort study.

Blood vessels, thrombosis & hemostasis·2026
Same author

The PERC-Peds rule: a promising step towards structured pulmonary embolism risk assessment in children.

The Lancet. Respiratory medicine·2026
Same author

Secondary Anticoagulation Prophylaxis for Children with Antiphospholipid Syndrome: A Systematic Review and Meta-Analysis.

Blood advances·2026
Same author

Treatment and outcomes of thromboembolism in paediatric patients with cardiac disease in a cardiac ICU: a single-centre retrospective study.

Cardiology in the young·2026
Same author

A novel US-based grading system for disease severity in sickle cell disease: the Sickle Cell Outcome Grading System (SCOGS).

The Lancet. Haematology·2026
Same author

Reply to: Comment on: Investigating Biomarkers for Inborn Errors of Immunity in a Prospective Study of Patients With Autoimmune Cytopenia.

Pediatric blood & cancer·2026

Related Experiment Video

Updated: Feb 24, 2026

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
06:01

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia

Published on: August 18, 2015

15.6K

Post-thrombotic syndrome in children.

Marisol Betensky1, Neil A Goldenberg1

  • 1Pediatric Thrombosis Program, Johns Hopkins All Children's Hospital, St. Petersburg, FL, USA; Department of Pediatrics, Division of Hematology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Thrombosis Research
|August 17, 2017
PubMed
Summary

Post-thrombotic syndrome (PTS) is a common complication of pediatric deep venous thrombosis (DVT). Understanding PTS pathophysiology and risk factors is crucial for early identification and better management in children.

Keywords:
ChildDeep venous thrombosisPost-thrombotic syndromeVenous thromboembolism

More Related Videos

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model
09:42

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model

Published on: June 4, 2021

3.5K
Author Spotlight: Utilizing Venoplasty Balloon Model in Rodents to Simulate Surgical Interventions for Deep Veins
05:44

Author Spotlight: Utilizing Venoplasty Balloon Model in Rodents to Simulate Surgical Interventions for Deep Veins

Published on: May 24, 2024

1.1K

Related Experiment Videos

Last Updated: Feb 24, 2026

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
06:01

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia

Published on: August 18, 2015

15.6K
A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model
09:42

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model

Published on: June 4, 2021

3.5K
Author Spotlight: Utilizing Venoplasty Balloon Model in Rodents to Simulate Surgical Interventions for Deep Veins
05:44

Author Spotlight: Utilizing Venoplasty Balloon Model in Rodents to Simulate Surgical Interventions for Deep Veins

Published on: May 24, 2024

1.1K

Area of Science:

  • Pediatric Medicine
  • Vascular Medicine
  • Hematology

Background:

  • Post-thrombotic syndrome (PTS) is a frequent and debilitating long-term complication following pediatric deep venous thrombosis (DVT).
  • The condition significantly impacts children's quality of life due to potential severe disability.
  • Current understanding of PTS pathophysiology, particularly the role of inflammation in acute DVT, is evolving.

Purpose of the Study:

  • To review and synthesize current evidence on the pathophysiology, risk factors, diagnosis, and management of pediatric PTS.
  • To highlight the need for improved risk prediction models for pediatric PTS.
  • To emphasize the importance of early identification for preventive and therapeutic interventions.

Main Methods:

  • Literature review of existing studies on pediatric deep venous thrombosis and post-thrombotic syndrome.
  • Analysis of diagnostic instruments like the Manco-Johnson Instrument and modified Villalta Scale.
  • Synthesis of evidence regarding prognostic indicators, therapeutic strategies, and long-term outcomes.

Main Results:

  • Few validated prognostic indicators for pediatric PTS development exist, hindering high-risk patient identification.
  • Limited evidence is available on effective therapeutic strategies and long-term outcomes for pediatric PTS.
  • Inflammation during acute DVT is increasingly recognized as a key factor in PTS development.

Conclusions:

  • Further research is essential to elucidate PTS pathophysiology and identify robust prognostic indicators in children.
  • Enhanced risk prediction models are needed to guide early interventions.
  • Early detection and management are critical to mitigate the severity and impact of pediatric PTS.